DTC, direct-to-patient, and consumer health marketing

DTC Campaign Checklist for Pharma: Brief to Launch

A step-by-step DTC campaign checklist for pharma teams: brief, audience, compliance, creative, media, privacy, measurement, QA, and launch readiness.

Christian Guerrero Published October 8, 2026 3 min read Part 4 of 10

The short answer

A DTC campaign checklist walks a pharma team from brief to launch: a clear objective and audience, approved claims and fair balance, privacy review of targeting and tracking, creative built for each channel, a media plan with frequency rules, a measurement plan with a control design, technical QA of tags and landing pages, and a launch-day monitoring plan. Most launch problems come from steps skipped under time pressure.

DTC campaigns involve many teams and many approvals. A checklist does not replace judgment, but it prevents the common failures: an audience that privacy never reviewed, a landing page that breaks tracking, or a launch with no way to measure outcomes.

1. Brief

[ ] Objective in measurable terms, tied to a barrier.
[ ] Primary audience and secondary audiences (caregivers, for example).
[ ] Ad type: product claim, reminder, or help-seeking. See the three ad types.
[ ] Budget and flight dates.
[ ] Success measures by rung. See the DTC KPI ladder.

2. Audience and targeting

[ ] Audience definitions written down.
[ ] Data sources listed with consent basis.
[ ] Privacy review completed for any health-related segment.
[ ] Exclusions set. See DTC exclusions and suppression.

3. Claims and compliance

[ ] Claims mapped to label and evidence.
[ ] Fair balance and risk presentation approved for each format.
[ ] Major statement meets FDA standards for broadcast and CTV.
[ ] Adequate provision approach confirmed for broadcast.

4. Creative

[ ] Versions for each channel and length.
[ ] Accessibility: captions, contrast, readable risk text. See accessible video creative.
[ ] Tested messages where possible.

5. Media plan

[ ] Channel roles defined.
[ ] Frequency targets and caps by channel, with a deduplicated measurement plan.
[ ] Suitability settings agreed.
[ ] Supply path and verification set.

6. Website and tracking

[ ] Landing pages approved and accessible.
[ ] Tags reviewed for privacy, especially on pages about conditions. See tracking pixel governance.
[ ] Consent management working.
[ ] Conversion events defined and tested.

7. Measurement

[ ] Outcome partner contracted.
[ ] Control design agreed before launch.
[ ] Baseline captured.
[ ] Reporting schedule set.

8. QA

[ ] Ad tags, trackers, and creative tested in every platform.
[ ] Click-through links and ISI links working.
[ ] Geography and audience settings checked.
[ ] See the prelaunch QA checklist.

9. Launch and first two weeks

[ ] Daily pacing and delivery check.
[ ] Adverse event monitoring process for comments and social. See adverse event monitoring.
[ ] Early quality review: viewability, IVT, suitability.
[ ] First deduplicated reach and frequency report.

Common mistakes

Starting media setup before privacy review of audiences.
Changing landing pages late without re-testing tags.
No control group agreed before launch.
Treating the checklist as a one-time form instead of a working tool.

Practical takeaway

Assign an owner and a due date to every line in sections 2, 6, and 7 at the brief stage. Those are the steps most often left until the week before launch, when fixing them is hardest.

Frequently asked questions

How long does a DTC campaign take to launch?

It varies, but review cycles, creative production, and media setup usually take several months for a new campaign, longer for TV.

What is the most commonly skipped DTC launch step?

Privacy review of website tracking and audience targeting, and measurement setup with a control group.

Who signs off on a DTC campaign?

Medical, legal, and regulatory reviewers approve materials; brand leadership approves plans; privacy teams approve data use.

Sources

External guidance and platform documentation change. Links were current at publication; check them again before relying on them for a decision.

Editorial note. Analysis and frameworks are the author's own and do not represent Acxiom or any current or former employer, client, or named platform. Examples labeled hypothetical or illustrative are not results from real campaigns. Nothing here is legal, regulatory, or medical advice.

Working through this decision on a real plan?

I work on health and pharma data, identity, and activation, after five years running HCP and DTC programmatic agency-side. Happy to talk through how this applies to your situation.

Book a 30-minute call Browse the library